產(chǎn)品描述: | Zomepirac sodium salt (McN-2783-21-98) is a potent prostaglandin biosynthesis inhibitor. Zomepirac sodium salt is a non-steroidal anti-inflammatory drug (NSAID). Zomepirac sodium salt can cause immune-mediated liver injury |
靶點: |
PGE synthase;PGESynthase;PDE |
參考文獻: |
1. Min Wang, et al. Hepatic covalent adduct formation with zomepirac in the CD26-deficient mouse. J Gastroenterol Hepatol. 2002 Jan;17(1):66-71. 2. T P Pruss, et al. Evaluation of the analgesic properties of zomepirac. J Clin Pharmacol. 1980 Apr;20(4):216-22. |
溶解性: |
Soluble in DMSO、H2O |
保存條件: |
2-8℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
3.188 ml |
15.938 ml |
31.877 ml |
5 mM |
0.638 ml |
3.188 ml |
6.375 ml |
10 mM |
0.319 ml |
1.594 ml |
3.188 ml |
50 mM |
0.064 ml |
0.319 ml |
0.638 ml |
|
注意: |
部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。 |